US clinical-stage US autoimmune drug developer Kyverna Therapeutics saw its shares leap more than 23% to $10.82 after its ...
Reuters Events’ flagship European cross-functional meeting for pharma leaders shaping the industry’s commercial and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback